A resource centre for driving innovation
OC Ventures is an international resource centre for those driving innovation. It brings together Osborne Clarke's deep specialist legal and sector expertise, guidance and support to businesses, entrepreneurs and investors in the ventures ecosystem. We support the most exciting emerging technologies, advising from start-up through venture financing and the growth journey beyond, whether continuing to sale, IPO or international expansion. Through OC Ventures, we seek to identify market disruptors and go on a growth journey with them.
OC Ventures is driven by Osborne Clarke's Venture Capital team in combination with experts from across our international network, delivering a joined up service to clients throughout the ventures ecosystem. Our specialists deliver outstanding legal knowledge as part of our 3D client strategy which blends legal skills and services with sector specialisms and an understanding of the macro drivers of transformation that shape our clients' challenges, in particular: decarbonisation, digital transformation and urban dynamics.
We have particular expertise in advising across a wide range of technology innovations, including artificial intelligence, use of data, augmented / virtual reality, blockchain, software and the metaverse, and a number of different innovation areas, including fintech, proptech, life sciences, digital health, energy innovation, ecommerce, emobility and smart cities.
The OC Ventures team is a market leader advising on spin-outs, technology transfer, commercialisation and investment transactions involving world-leading universities and research institutions.
Tap into our training, knowledge and bespoke resources through a selection of videos, webinars, insights and in-depth guides for the ventures ecosystem.
Helping create, build and grow ventures
Osborne Clarke can provide investors, companies, founders and management teams with guidance and support to help create, build and grow businesses from initial start up through to growth and beyond.
There will be much to plan for as a start-up moves from idea to launch in often highly competitive markets – not least, the legal and business foundations of its operations. We can guide you as you take these steps to prepare and incorporate your company, and deal with founder and shareholder arrangements, initial funding, identifying and securing intellectual property (IP) and everything else you need to get your business up and running.
Strong governance needs to be a priority at the outset for start-up businesses and not an afterthought. We can work with you to design and implement the right agreements between founders and investors and advise on board composition and arrangements between directors, shareholders and the company.
Finance and investor interest are crucial for the progress of any start-up journey. Our market-leading team advises companies, founders and investors on VC transactions from Seed and Series A to the largest international institutional deals, advising on 400-plus fundraisings annually across all technology sectors.
Appropriate protection and commercialisation of intellectual property (IP) rights is critical. Our experts can help you develop an IP strategy and advise on the right steps nationally and internationally to ensure your IP assets are robustly protected and can be best exploited to generate revenue and shareholder value.
The success of high-growth start-ups hinges on the right people and talent in place to progress the business, which, in turn, requires the right employment, consultancy and adviser arrangements at each stage of development. We can assist and advise on these and provide deep knowledge of market practice and sectors to ensure your people and your company are appropriately protected.
Identifying the right incentives is crucial for ensuring that start-ups have and keep the best people who continue to bring energy to the business. Our dedicated Incentives team can advise on share options and other incentives for individuals through to company-wide schemes, with the right focus on tax efficiency and market practice to ensure you can attract, recruit and motivate the best people.
Commercial agreements, data, employment, regulation and protection, real estate, disputes and other aspects of business operations require close attention and expert knowledge. Our specialist advisory teams can ensure that your business operations are properly covered, with teams that have the sector and market experience to give you the best advice.
When your company is considering growth by national or international acquisition or joint venture, our Corporate team can expertly guide you through the strategy, planning and execution of the transaction process.
OC Ventures' core mission is to ensure you and your business are guided and assisted through the entire growth journey so that you are best prepared for a liquidity event, whether that's a trade sale, initial public offering (IPO) or private-equity buyout. Our specialist teams have unparalleled experience in taking ventures, whatever stage they are at, through planning and executing an exit to achieve the best possible outcome.
We advise institutional VC and growth capital investors on all stages of the life of investment structures, throughout the fundraising, investing and exit cycles.
OC Ventures supports the most exciting emerging companies across tech and life sciences, advising from start-up through venture and growth financing and the growth journey beyond, whether continuing to sale, IPO or international expansion. Here's how we've helped clients through their ventures journey.
Work highlights from across the ventures ecosystem
We advised Fintern on Abound's £500m funding to accelerate growth of affordable loans.
We advised Flock the London-based insurance technology company that uses real-time data to enable and incentivise safer driving, on a $38M series B fundraising led by Octopus Ventures, one of the largest and most active venture capital investors in Europe.
We advised AlbionVC as the world's first cybersecurity human risk management platform, OutThink, which combines machine learning, natural language processing and applied psychology to identify individuals' attitudes and behaviours, has raised £8.8 million in its latest funding round.
We advised AlbionVC as Toqio has secured £17.2m in Series A funding, which also includes a £1.1m grant from a public organisation for technology development in Spain.
Argonaut Therapeutics Ltd
We advised Argonaut Therapeutics Ltd on its merger with Celleron Therapeutics Ltd.
We advised Foresight, a leading listed regional private equity and infrastructure investment manager, on the first close of its Foresight Scotland Fund.
UCL Technology Fund
We advised UCL Technology Fund on lead investment in Bloomsbury Genetic Therapies' £5 million financing round.
We advised BGF on its investment in autonomous vehicle software global leader Oxbotica's Series C funding round raising US$140 million. The funding will be used to drive Oxbotica's global expansion and accelerate commercialisation of its technology.
We advised digital health startup Mediktor in an 11m euro series B round led by Swiss fund MTIP. We already advised Mediktor in their 3m euro series A round led by Alta Life Sciences.
We advised on the establishment of Giant Ventures and the launch of its Fund I and Fund II.
We advised Barcelona-based HR SaaS developer Factorial in an $80m series B finance round, led by Tiger Global, with co-investment by funds Creandum and CRV.
Mangrove Capital Partners and 14W
We advised Mangrove Capital Partners and 14W as lead investors in a $30m finance round in online travel agency Exoticca.
Accel and 14W
We advised Accel and 14W on an $181m series F funding round led by Korelya as investors in second-hand marketplace Wallapop.
Advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité FTQ in US$13.6 million funding round.
Pink Salt Ventures
We advised on the establishment of Pink Salt Ventures and the launch of its first fund.
Advised pioneering AI lung cancer diagnosis innovator Optellum on US$14m Series A funding round.
Advent Life Sciences
We advised Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, on its lead investment in Proximie's US$80 million Series C funding round.
We advised Super Payments on its £22.5 million fundraise led by Accel to transform the online shopping experience.
Advised Causeway Technologies on a £120 million investment to fund strategic acquisitions and accelerate its organic growth strategy to digitally connect the construction supply chain through further development of its Cloud Platform.
Highland Europe and Frog Capital
We advised Highland Europe and Frog Capital on additional investment in Modulr an embedded payments platform for digital businesses.
We advised on the launch of the Foresight Williams joint venture (and Foresight Williams EIS Fund).
Advised Highland Europe on its series C$100 million investment in SaaS platform Plentific.
We advised Fintern on fundraising as it secures £40 million of capital. Investment will help scale its credit technology and power fair finance across the UK and beyond.
We advised Nexeon on significant US$80 million funding to scale up production of step change battery materials. Through the transaction, Nexeon enters into a strategic partnership with SKC, a major global battery and semiconductor
We advised Eight Roads on its lead in 7bridges' $17 million Series A fundraising round. Eight Roads led the round together with Local Globe and enterprise VC Crane. With this round 7 bridges has raised just over $20 million to date.
Osborne Clarke has advised DoorDash on USD 750 million Series B financing round of rapid delivery firm Flink SE.
Warburg Pincus and Hollyport Capital
Osborne Clarke advised Warburg Pincus and Hollyport Capital on Series D financing round of McMakler.
We advised Tiger Global on its lead investment in Lifebit's $60 million series B funding round. The round will field the rapid adoption of biomedical software around the world.
Science Creates Ventures, Foresight Williams Technology and BGF
We advised Science Creates Ventures, Foresight Williams Technology and BGF on their involvement in Forefront RF's initial £1.5 million investment round, which also included The Cambridge Angels.
We advised Flock on $17 million fundraise led by social capital to reinvent insurance for connected vehicles. A funding to supercharge its expansion into new geographies and product lines.
We advised BGF on its lead investment in a £58 million funding of disruptive femtech firm Elvie, the revolutionary global health and lifestyle brand developing iconic products for women.
We advised on the launch of Passion Capital's third venture fund.
We advised Element Ventures, a global venture capital fund, as the lead investor in Coincover's $9.2 million Series A round. The funding will be used to drive awareness of the product offering and grow the team so that Coincover can support more of the crypto market.
We advised NeRRe Therapeutics on its £20 million Series B2 financing round. The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners and existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed.
BGF and CPT Capital
We advised BGF and CPT Capital on a £11 million equity fundraising round for THIS, a plant-based, meat alternative brand.
We advised digital onboarding platform, Thirdfort, on its latest £1.5 million fund raising. Leading digital entrepreneur Alex Chesterman is among the high profile names to have reinvested. The funding will support expansion in the legal and property sectors for the digital ID and anti-money-laundering start up.
Illuminate Financial Management
We advised on the launch of all of Illuminate's funds (three in total), focusing on early-stage investments in the global capital markets Fintech market.
We advised BGF on a £10.5 million minority investment in e2e-assure, an established, fast-growth cybersecurity. The Funding will be used to facilitate international growth and expand its go-to marketing offering.
Science Creates Ventures
We advised on the establishment of Science Creates Ventures and the launch of its first fund.
We advised Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, on its $53 million (£38 million) Series B financing round.
We advised Brazilian venture capital manager Monashees, on its lead investment in AI energy analytics start-up Vortexa's $19m Series B investment round.
We advised firstminute capital on the launch of firstminute capital I, and firstminute capital II as well as series of SPV LP's.
Clean Growth Fund
We advised the Clean Growth Fund on a £6 million co-investment with Gulf Oil in Indra, the UK's leading smart charging technology company.
We advised on the launch of the second early-stage technology fund from firstminute capital raising $111 million to date.
We advised BFG on its £6 million investment in Amdaris, an industry-leading software developer and digital transformation specialist, to support its organic and acquisitive growth strategy.
We advised InReach on the launch of their first fund targeting seed and pre Series A investments in European technology companies
We advised MMC on the launch of the MMC Greater London Fund and the MMC Scale up Fund 2019 as well as a series of SPV LP's.
We advised on the the launch of all of Notion's UK-based venture and growth capital funds.
We advised on the launch of PiLabs' third European proptech fund.